Skip to main content
. Author manuscript; available in PMC: 2020 Aug 11.
Published before final editing as: Dev Psychopathol. 2019 Feb 11:1–9. doi: 10.1017/S0954579418001682

Table 3.

Strategy Use by Psychosis Vulnerability and Sex

Studies 1–3
Psychosis Group F = 1.82 d = 0.26
Sex F = 0.24 d = 0.06
Strategy F = 79.04*** d = 0.91
Psychosis Group × Sex F = 2.14 d = 0.31
Psychosis Group × Strategy F = 977*** d = 0.68
Sex × Strategy F = 1.28 d = 0.17
Psychosis Group × Sex × Strategy F = 6.42** d = 0.59
One-Way ANOVAs Across Groups
 Reappraisal - Female F = 759*** d = 0.61
 Suppression - Female F = 1.82 d = 0.30
 Reappraisal - Male F = 1.81 d = 0.29
 Suppression - Male F = 3.55* d = 0.40
One-Way ANOVAs Within Groups Comparing Sexes
 Reappraisal
  PLE (M vs F) F = 7.68** d = 0.35
  CHR (M vs F) F = 0.67 d = 0.32
  SZ (M vs F) F = 0.31 d = 0.14
 Suppression
  PLE (M vs F) F = 11.02*** d = 0.42
  CHR (M vs F) F = 4.29* d = 0.81
  SZ (M vs F) F = 3.11 d = 0.51

Note.

***

p < 0.001;

**

p < 0.01;

*

p < 0.05.

PLE = individuals with psychotic-like experiences; NPLE = individuals without psychotic-like experiences; CHR = individuals at clinical high-risk; CN = controls; SZ = schizophrenia outpatients; M = males; F = females.